Skip to main content

DCVMN Gavi board representatives on the side of the Board Chair, Dr. Ngozi Okonjo-Iweala, at her first Board meeting

Geneva, 22nd June 2016 – DCVMN Gavi Board member, Mr. Adar Poonawalla and his alternate Mr. Juliman Fuad, welcomed the new Chair at her first Board meeting and supported the board decisions on WHO’s malaria vaccine pilots, as well as the forward looking approach towards delivering on the Vaccine Alliance’s 2016 to 2020 supply strategy, to help foster healthy markets for vaccines and other immunisation-related products to benefit Gavi-supported countries and those who transition from Gavi support. The new strategy takes a long-term approach, drawing on the expertise of a more diverse group of partners and engaging with an expanded group of vaccine manufacturers. In this context, Gavi will create a platform to share and meet country needs, innovation priorities, and inform manufacturers’ investment decisions. The Board also approved a new framework for the Health System and Immunisation Strengthening framework to ensure that Gavi’s investments are in fact able to help countries reach children who are currently missing out on essential vaccines, as part of the Gavi commitment to universal Health Coverage and the Sustainable Development Goals. More details available at

Attached documents